Get started
Author

DK McGuire

Cardiovascular Risk in Diabetes Mellitus: Complication of the Disease or of Antihyperglycemic Medications
2015 · CA Alvarez, I Lingvay, et al. · Clinical Pharmacology & Therapeutics · 41
Ausgangscharakteristika der DECLARE-TIMI-58-Studienpopulation
2018 · I Raz, MP Bonaca, et al. · Diabetologie und Stoffwechsel · 4
Diabetes and cardiovascular disease: current opinions and future directions.
1999 · D K McGuire, R M Califf · PubMed · 3
Effects of once-weekly semaglutide on coronary outcomes in patients with type 2 diabetes mellitus with or at high risk for cardiovascular disease: insights from the SUSTAIN-6 trial
2022 · A Kolkailah, A Aharonovich, et al. · European Journal of Preventive Cardiology · 1
Interrelationship between Reduction in Weight and Adiposity Indices and Improvement in Cardiovascular (CV) Death and Heart Failure (HF) Outcomes with Empagliflozin in Patients with Type 2 Diabetes (T2D) in EMPA-REG OUTCOME®
2018 · IJ Neeland, DK McGuire, et al. · Diabetologie und Stoffwechsel · 1
Cardiovascular outcomes by baseline blood pressure control status in persons with type 2 diabetes at high cardiovascular risk treated with oral semaglutide
2026 · N Poulter, S L Mulvagh, et al. · European Heart Journal
PDF
Efficacy of sotagliflozin 400 mg/day in 1402 patients with type 1 diabetes treated with any insulin regimen (inTandem 3)
2018 · SK Garg, RR Henry, et al. · Diabetologie und Stoffwechsel
Works count: 7
Citation count: 50
H-index: 3
I10-index: 1
Year
Topic
Type